Switch to:
Also traded in: Argentina, Brazil, Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.36
NYSE:MDT's Cash-to-Debt is ranked lower than
81% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. NYSE:MDT: 0.36 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:MDT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15  Med: 0.6 Max: 9.58
Current: 0.36
0.15
9.58
Equity-to-Asset 0.51
NYSE:MDT's Equity-to-Asset is ranked lower than
62% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. NYSE:MDT: 0.51 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:MDT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37  Med: 0.57 Max: 0.82
Current: 0.51
0.37
0.82
Interest Coverage 4.05
NYSE:MDT's Interest Coverage is ranked lower than
88% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: 93.54 vs. NYSE:MDT: 4.05 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:MDT' s Interest Coverage Range Over the Past 10 Years
Min: 3.82  Med: 10.69 Max: 16.28
Current: 4.05
3.82
16.28
Piotroski F-Score: 6
Altman Z-Score: 2.74
Beneish M-Score: -2.48
WACC vs ROIC
7.57%
6.83%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 17.72
NYSE:MDT's Operating Margin % is ranked higher than
88% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. NYSE:MDT: 17.72 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:MDT' s Operating Margin % Range Over the Past 10 Years
Min: 16.71  Med: 23.03 Max: 30.17
Current: 17.72
16.71
30.17
Net Margin % 13.51
NYSE:MDT's Net Margin % is ranked higher than
85% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. NYSE:MDT: 13.51 )
Ranked among companies with meaningful Net Margin % only.
NYSE:MDT' s Net Margin % Range Over the Past 10 Years
Min: 12.27  Med: 18.81 Max: 22.78
Current: 13.51
12.27
22.78
ROE % 7.83
NYSE:MDT's ROE % is ranked higher than
65% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. NYSE:MDT: 7.83 )
Ranked among companies with meaningful ROE % only.
NYSE:MDT' s ROE % Range Over the Past 10 Years
Min: 6.72  Med: 19.6 Max: 27.52
Current: 7.83
6.72
27.52
ROA % 3.99
NYSE:MDT's ROA % is ranked higher than
66% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. NYSE:MDT: 3.99 )
Ranked among companies with meaningful ROA % only.
NYSE:MDT' s ROA % Range Over the Past 10 Years
Min: 3.43  Med: 10.42 Max: 14.3
Current: 3.99
3.43
14.3
ROC (Joel Greenblatt) % 58.79
NYSE:MDT's ROC (Joel Greenblatt) % is ranked higher than
90% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 4.02 vs. NYSE:MDT: 58.79 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:MDT' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 51.21  Med: 66.98 Max: 82.85
Current: 58.79
51.21
82.85
3-Year Revenue Growth Rate 7.80
NYSE:MDT's 3-Year Revenue Growth Rate is ranked higher than
63% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. NYSE:MDT: 7.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:MDT' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.2  Med: 12.6 Max: 17.9
Current: 7.8
4.2
17.9
3-Year EBITDA Growth Rate 4.10
NYSE:MDT's 3-Year EBITDA Growth Rate is ranked lower than
52% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 5.60 vs. NYSE:MDT: 4.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:MDT' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -15.5  Med: 9.6 Max: 24
Current: 4.1
-15.5
24
3-Year EPS without NRI Growth Rate -9.70
NYSE:MDT's 3-Year EPS without NRI Growth Rate is ranked lower than
69% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. NYSE:MDT: -9.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:MDT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -9.7  Med: 13.5 Max: 27.1
Current: -9.7
-9.7
27.1
GuruFocus has detected 6 Warning Signs with Medtronic PLC $NYSE:MDT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:MDT's 10-Y Financials

Financials (Next Earnings Date: 2017-05-25)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MDT Guru Trades in Q1 2016

George Soros 11,100 sh (New)
Signature Select Canadian Fund 126,900 sh (New)
Manning & Napier Advisors, Inc 7,795,870 sh (+55.41%)
Pioneer Investments 4,619,992 sh (+8.21%)
David Carlson 930,000 sh (+3.33%)
John Buckingham 23,323 sh (+2.35%)
Jeff Auxier 139,773 sh (+0.36%)
PRIMECAP Management 15,196,981 sh (+0.06%)
John Hussman 175,000 sh (unchged)
Louis Moore Bacon 50,000 sh (unchged)
Ray Dalio Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Steven Cohen Sold Out
Dodge & Cox 6,838,035 sh (-0.44%)
Mairs and Power 3,017,700 sh (-3.99%)
First Eagle Investment 1,833,793 sh (-5.48%)
Mario Gabelli 37,877 sh (-5.57%)
Vanguard Health Care Fund 18,332,133 sh (-8.71%)
Barrow, Hanley, Mewhinney & Strauss 27,494,507 sh (-9.21%)
Robert Olstein 96,000 sh (-11.11%)
Ken Fisher 5,018 sh (-15.02%)
Jeremy Grantham 3,706,658 sh (-18.46%)
Ruane Cunniff 3,895 sh (-23.25%)
Diamond Hill Capital 2,515,263 sh (-26.80%)
HOTCHKIS & WILEY 2,374,011 sh (-38.83%)
Bill Nygren 2,490,000 sh (-40.57%)
Keeley Asset Management Corp 12,172 sh (-51.85%)
» More
Q2 2016

MDT Guru Trades in Q2 2016

T Rowe Price Equity Income Fund 750,000 sh (New)
Jim Simons 573,141 sh (New)
Joel Greenblatt 167,825 sh (New)
Paul Tudor Jones 4,000 sh (New)
Steven Cohen 125,000 sh (New)
Jeremy Grantham 4,444,824 sh (+19.91%)
Pioneer Investments 4,975,460 sh (+7.69%)
Vanguard Health Care Fund 19,159,633 sh (+4.51%)
David Carlson 930,000 sh (unchged)
Bill Nygren 2,490,000 sh (unchged)
George Soros Sold Out
Jeff Auxier 139,173 sh (-0.43%)
Mairs and Power 2,994,818 sh (-0.76%)
PRIMECAP Management 14,981,004 sh (-1.42%)
Diamond Hill Capital 2,470,305 sh (-1.79%)
Dodge & Cox 6,452,264 sh (-5.64%)
Ken Fisher 4,716 sh (-6.02%)
John Buckingham 21,869 sh (-6.23%)
Keeley Asset Management Corp 11,133 sh (-8.54%)
Manning & Napier Advisors, Inc 7,062,815 sh (-9.40%)
Mario Gabelli 34,285 sh (-9.48%)
Ruane Cunniff 3,395 sh (-12.84%)
Barrow, Hanley, Mewhinney & Strauss 21,090,262 sh (-23.29%)
John Hussman 125,000 sh (-28.57%)
HOTCHKIS & WILEY 1,653,662 sh (-30.34%)
Robert Olstein 66,000 sh (-31.25%)
First Eagle Investment 1,106,014 sh (-39.69%)
» More
Q3 2016

MDT Guru Trades in Q3 2016

Ray Dalio 31,000 sh (New)
Eaton Vance Worldwide Health Sciences Fund 665,629 sh (New)
Ken Fisher 4,949 sh (+4.94%)
Jeremy Grantham 4,593,000 sh (+3.33%)
Paul Tudor Jones 4,100 sh (+2.50%)
T Rowe Price Equity Income Fund 750,000 sh (unchged)
John Hussman 125,000 sh (unchged)
David Carlson 930,000 sh (unchged)
Keeley Asset Management Corp 11,133 sh (unchged)
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Jeff Auxier 139,123 sh (-0.04%)
Mairs and Power 2,960,586 sh (-1.14%)
Vanguard Health Care Fund 18,747,933 sh (-2.15%)
PRIMECAP Management 14,482,669 sh (-3.33%)
Diamond Hill Capital 2,385,913 sh (-3.42%)
Pioneer Investments 4,769,969 sh (-4.13%)
Manning & Napier Advisors, Inc 6,658,775 sh (-5.72%)
Barrow, Hanley, Mewhinney & Strauss 19,033,448 sh (-9.75%)
Ruane Cunniff 3,000 sh (-11.63%)
Dodge & Cox 5,584,858 sh (-13.44%)
Mario Gabelli 26,273 sh (-23.37%)
Robert Olstein 48,432 sh (-26.62%)
John Buckingham 16,032 sh (-26.69%)
Signature Select Canadian Fund 78,800 sh (-37.90%)
HOTCHKIS & WILEY 1,012,932 sh (-38.75%)
Bill Nygren 1,140,000 sh (-54.22%)
First Eagle Investment 397,038 sh (-64.10%)
Jim Simons 191,241 sh (-66.63%)
» More
Q4 2016

MDT Guru Trades in Q4 2016

Richard Pzena 4,287 sh (New)
Paul Tudor Jones 42,798 sh (+943.85%)
Jim Simons 878,141 sh (+359.18%)
T Rowe Price Equity Income Fund 1,810,000 sh (+141.33%)
Robert Olstein 110,000 sh (+127.12%)
Ray Dalio 62,300 sh (+100.97%)
Dodge & Cox 10,688,625 sh (+91.39%)
Bill Nygren 1,640,000 sh (+43.86%)
HOTCHKIS & WILEY 1,251,351 sh (+23.54%)
Ken Fisher 6,096 sh (+23.18%)
John Buckingham 18,321 sh (+14.28%)
Pioneer Investments 5,253,307 sh (+10.13%)
Diamond Hill Capital 2,615,402 sh (+9.62%)
Barrow, Hanley, Mewhinney & Strauss 20,528,595 sh (+7.86%)
Mairs and Power 3,142,079 sh (+6.13%)
Jeff Auxier 146,923 sh (+5.61%)
David Carlson 970,000 sh (+4.30%)
Vanguard Health Care Fund 19,256,523 sh (+2.71%)
Mario Gabelli 26,774 sh (+1.91%)
Manning & Napier Advisors, Inc 6,772,888 sh (+1.71%)
John Hussman 125,000 sh (unchged)
Ruane Cunniff 3,000 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 665,629 sh (unchged)
Keeley Asset Management Corp Sold Out
Jeremy Grantham 4,309,570 sh (-6.17%)
PRIMECAP Management 12,767,922 sh (-11.84%)
First Eagle Investment 1,434 sh (-99.64%)
» More
» Details

Insider Trades

Latest Guru Trades with MDT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NYSE:ABT, NYSE:SYK, NYSE:BSX, NAS:ISRG, NYSE:ZBH, NYSE:EW, OTCPK:SNNUF, NAS:ALGN, NYSE:TFX, NYSE:VAR, OTCPK:SONVY, OTCPK:SDMHF, OTCPK:CNVVY, OTCPK:CHEOY, NAS:ABMD, OTCPK:WILYY, NAS:MASI, OTCPK:FSPKF, NAS:NUVA, OTCPK:EKTAF » details
Traded in other countries:MDT.Argentina, MDTC34.Brazil, 2M6.Germany, MDTN.Mexico, MDT.Switzerland, 0QYG.UK,
Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in three operating segments that manufacture and sell device-based medical therapies.

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to health-care institutions and physicians in the United States and overseas. Foreign sales account for about 41% of the company's total sales.

Ratios

vs
industry
vs
history
PE Ratio 28.60
MDT's PE Ratio is ranked lower than
52% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 27.89 vs. MDT: 28.60 )
Ranked among companies with meaningful PE Ratio only.
MDT' s PE Ratio Range Over the Past 10 Years
Min: 10.17  Med: 20.53 Max: 54.09
Current: 28.6
10.17
54.09
Forward PE Ratio 16.39
MDT's Forward PE Ratio is ranked higher than
91% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 23.04 vs. MDT: 16.39 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 28.60
MDT's PE Ratio without NRI is ranked lower than
51% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. MDT: 28.60 )
Ranked among companies with meaningful PE Ratio without NRI only.
MDT' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.17  Med: 20.53 Max: 54.09
Current: 28.6
10.17
54.09
Price-to-Owner-Earnings 21.39
MDT's Price-to-Owner-Earnings is ranked higher than
70% of the 102 Companies
in the Global Medical Devices industry.

( Industry Median: 30.77 vs. MDT: 21.39 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MDT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.24  Med: 18.96 Max: 51.3
Current: 21.39
9.24
51.3
PB Ratio 2.24
MDT's PB Ratio is ranked higher than
65% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.35 vs. MDT: 2.24 )
Ranked among companies with meaningful PB Ratio only.
MDT' s PB Ratio Range Over the Past 10 Years
Min: 1.78  Med: 2.85 Max: 6.3
Current: 2.24
1.78
6.3
PS Ratio 3.87
MDT's PS Ratio is ranked lower than
56% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.31 vs. MDT: 3.87 )
Ranked among companies with meaningful PS Ratio only.
MDT' s PS Ratio Range Over the Past 10 Years
Min: 1.93  Med: 3.49 Max: 5.54
Current: 3.87
1.93
5.54
Price-to-Free-Cash-Flow 21.97
MDT's Price-to-Free-Cash-Flow is ranked higher than
63% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 29.73 vs. MDT: 21.97 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.19  Med: 14.91 Max: 64.89
Current: 21.97
9.19
64.89
Price-to-Operating-Cash-Flow 17.63
MDT's Price-to-Operating-Cash-Flow is ranked higher than
58% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. MDT: 17.63 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.14  Med: 12.98 Max: 28.33
Current: 17.63
8.14
28.33
EV-to-EBIT 23.57
MDT's EV-to-EBIT is ranked higher than
51% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 23.96 vs. MDT: 23.57 )
Ranked among companies with meaningful EV-to-EBIT only.
MDT' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.7  Med: 15.8 Max: 30.9
Current: 23.57
8.7
30.9
EV-to-EBITDA 15.53
MDT's EV-to-EBITDA is ranked higher than
55% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 17.54 vs. MDT: 15.53 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.4  Med: 13.3 Max: 21.7
Current: 15.53
7.4
21.7
PEG Ratio 7.00
MDT's PEG Ratio is ranked lower than
77% of the 77 Companies
in the Global Medical Devices industry.

( Industry Median: 2.47 vs. MDT: 7.00 )
Ranked among companies with meaningful PEG Ratio only.
MDT' s PEG Ratio Range Over the Past 10 Years
Min: 1.1  Med: 1.91 Max: 18.15
Current: 7
1.1
18.15
Shiller PE Ratio 28.29
MDT's Shiller PE Ratio is ranked higher than
84% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 54.18 vs. MDT: 28.29 )
Ranked among companies with meaningful Shiller PE Ratio only.
MDT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.42  Med: 22.12 Max: 39.84
Current: 28.29
14.42
39.84
Current Ratio 1.77
MDT's Current Ratio is ranked lower than
65% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. MDT: 1.77 )
Ranked among companies with meaningful Current Ratio only.
MDT' s Current Ratio Range Over the Past 10 Years
Min: 0.88  Med: 2.42 Max: 6.8
Current: 1.77
0.88
6.8
Quick Ratio 1.48
MDT's Quick Ratio is ranked lower than
58% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. MDT: 1.48 )
Ranked among companies with meaningful Quick Ratio only.
MDT' s Quick Ratio Range Over the Past 10 Years
Min: 0.66  Med: 1.93 Max: 6.46
Current: 1.48
0.66
6.46
Days Inventory 142.75
MDT's Days Inventory is ranked lower than
58% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 125.58 vs. MDT: 142.75 )
Ranked among companies with meaningful Days Inventory only.
MDT' s Days Inventory Range Over the Past 10 Years
Min: 132.14  Med: 142.57 Max: 164.01
Current: 142.75
132.14
164.01
Days Sales Outstanding 67.79
MDT's Days Sales Outstanding is ranked lower than
51% of the 240 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. MDT: 67.79 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.79  Med: 81.9 Max: 92.09
Current: 67.79
67.79
92.09
Days Payable 61.65
MDT's Days Payable is ranked higher than
53% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. MDT: 61.65 )
Ranked among companies with meaningful Days Payable only.
MDT' s Days Payable Range Over the Past 10 Years
Min: 32.49  Med: 51.72 Max: 93.14
Current: 61.65
32.49
93.14

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.07
MDT's Dividend Yield % is ranked higher than
66% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.63 vs. MDT: 2.07 )
Ranked among companies with meaningful Dividend Yield % only.
MDT' s Dividend Yield % Range Over the Past 10 Years
Min: 0.75  Med: 1.89 Max: 2.93
Current: 2.07
0.75
2.93
Dividend Payout Ratio 0.59
MDT's Dividend Payout Ratio is ranked lower than
55% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. MDT: 0.59 )
Ranked among companies with meaningful Dividend Payout Ratio only.
MDT' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.18  Med: 0.31 Max: 0.61
Current: 0.59
0.18
0.61
3-Year Dividend Growth Rate 13.50
MDT's 3-Year Dividend Growth Rate is ranked higher than
66% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. MDT: 13.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
MDT' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 7.6  Med: 14.9 Max: 24.9
Current: 13.5
7.6
24.9
Forward Dividend Yield % 2.12
MDT's Forward Dividend Yield % is ranked higher than
73% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 1.63 vs. MDT: 2.12 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.36
MDT's 5-Year Yield-on-Cost % is ranked higher than
75% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 1.88 vs. MDT: 3.36 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
MDT' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.22  Med: 3.07 Max: 4.76
Current: 3.36
1.22
4.76
3-Year Average Share Buyback Ratio -11.30
MDT's 3-Year Average Share Buyback Ratio is ranked lower than
69% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. MDT: -11.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDT' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11.3  Med: 1 Max: 2.5
Current: -11.3
-11.3
2.5

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.27
MDT's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
80% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. MDT: 1.27 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDT' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.76  Med: 1.41 Max: 6.95
Current: 1.27
0.76
6.95
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.67
MDT's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
68% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. MDT: 2.67 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.11
MDT's Price-to-Median-PS-Value is ranked lower than
53% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 1.07 vs. MDT: 1.11 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDT' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.67  Med: 1.42 Max: 3.62
Current: 1.11
0.67
3.62
Earnings Yield (Greenblatt) % 4.24
MDT's Earnings Yield (Greenblatt) % is ranked higher than
77% of the 339 Companies
in the Global Medical Devices industry.

( Industry Median: -0.81 vs. MDT: 4.24 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDT' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.2  Med: 6.3 Max: 11.5
Current: 4.24
3.2
11.5
Forward Rate of Return (Yacktman) % 8.57
MDT's Forward Rate of Return (Yacktman) % is ranked lower than
55% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 9.01 vs. MDT: 8.57 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MDT' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 7.2  Med: 14.1 Max: 19.5
Current: 8.57
7.2
19.5

More Statistics

Revenue (TTM) (Mil) $29,361
EPS (TTM) $ 2.83
Beta0.85
Short Percentage of Float0.63%
52-Week Range $69.35 - 89.27
Shares Outstanding (Mil)1,368.88

Analyst Estimate

Apr17 Apr18 Apr19
Revenue (Mil $) 29,678 30,898 32,270
EPS ($) 4.56 4.96 5.39
EPS without NRI ($) 4.56 4.96 5.39
EPS Growth Rate
(Future 3Y To 5Y Estimate)
7.52%
Dividends per Share ($) 1.64 1.90 2.28
» More Articles for NYSE:MDT

Headlines

Articles On GuruFocus.com
Dividend Aristocrats: Medtronic vs. Becton, Dickinson & Company Mar 19 2017 
Top 7 Dividend Health Care Stocks Jan 05 2017 
52-Week Company Lows Jan 05 2017 
52-Week Company Lows Dec 29 2016 
The 10 Best Dividend Aristocrats for 2017 and Beyond Dec 23 2016 
52-Week Company Lows Dec 22 2016 
Weekly Top Insider Buys Highlights Dec 16 2016 
52-Week Company Lows Dec 15 2016 
52-Week Company Lows Dec 08 2016 
52-Week Company Lows Dec 01 2016 

More From Other Websites
MEDTRONIC PLC Files SEC form 8-K, Other Events Mar 22 2017
Medtronic Receives FDA Approval for CoreValve(TM) Evolut(TM) Pro Transcatheter Valve with Advanced... Mar 22 2017
3:40 am Medtronic prices $2 bln of Senior Notes in 3 tranches Mar 22 2017
Medtronic Announces Pricing of $2 Billion of Senior Notes Mar 21 2017
Here's How I Invest My Own Retirement Cash Mar 21 2017
Medtronic Global Holdings SCA -- Moody's assigns A3 to Medtronic's new note offerings; outlook... Mar 21 2017
Medtronic Stock Trades Ex-Dividend Wednesday (MDT) Mar 21 2017
Has Masimo Become Too Expensive to Hold? Mar 20 2017
Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve Mar 20 2017
Mazor Robotics-Medtronic's Mazor X Partnership Strengthens Mar 20 2017
Dividend Aristocrats: Medtronic vs. Becton, Dickinson & Company Mar 19 2017
Less-Invasive Treatment Yielded Similar Outcome as Open-Heart Surgery, Study Finds Mar 17 2017
Medtronic Does Heart-Valve Study, And Rivals Reap The Benefits Mar 17 2017
Transcatheter Device By Medtronic PLC (MDT) Gets FDA Nod Mar 17 2017
Less-Invasive Heart Procedure Yielded Similar Outcome as Surgery, Study Finds Mar 17 2017
Landmark SURTAVI Clinical Trial Shows Transcatheter Aortic Valve Replacement (TAVR) with the... Mar 17 2017
Medtronic heart valve replacement succeeds in intermediate-risk patients-study Mar 17 2017
Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference Mar 16 2017
Medtronic's Melody TPV Wins FDA for Less-Invasive Treatment Mar 16 2017
Blog Coverage Cesca Therapeutics Announces Encouraging Results from a Study of its Treatment of... Mar 16 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)